Eurobio Scientific Return On Asset vs. Beta

ALERS Stock   25.75  0.05  0.19%   
Based on the measurements of profitability obtained from Eurobio Scientific's financial statements, Eurobio Scientific SA may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Eurobio Scientific's ability to earn profits and add value for shareholders.
For Eurobio Scientific profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Eurobio Scientific to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Eurobio Scientific SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Eurobio Scientific's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Eurobio Scientific SA over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Eurobio Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eurobio Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eurobio Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Eurobio Scientific Beta vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Eurobio Scientific's current stock value. Our valuation model uses many indicators to compare Eurobio Scientific value to that of its competitors to determine the firm's financial worth.
Eurobio Scientific SA is number one stock in return on asset category among its peers. It also is number one stock in beta category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eurobio Scientific's earnings, one of the primary drivers of an investment's value.

Eurobio Beta vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Eurobio Scientific

Return On Asset

 = 

Net Income

Total Assets

 = 
0.23
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Eurobio Scientific

Beta

 = 

Covariance

Variance

 = 
-0.0704
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

Eurobio Beta Comparison

Eurobio Scientific is currently under evaluation in beta category among its peers.

Beta Analysis

As returns on the market increase, returns on owning Eurobio Scientific are expected to decrease at a much lower rate. During the bear market, Eurobio Scientific is likely to outperform the market.

Eurobio Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Eurobio Scientific. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Eurobio Scientific position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Eurobio Scientific's important profitability drivers and their relationship over time.

Use Eurobio Scientific in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eurobio Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eurobio Scientific will appreciate offsetting losses from the drop in the long position's value.

Eurobio Scientific Pair Trading

Eurobio Scientific SA Pair Trading Analysis

The ability to find closely correlated positions to Eurobio Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eurobio Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eurobio Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eurobio Scientific SA to buy it.
The correlation of Eurobio Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eurobio Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eurobio Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eurobio Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Eurobio Scientific position

In addition to having Eurobio Scientific in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Climate Change Thematic Idea Now

Climate Change
Climate Change Theme
Large and medium sized entities that are committing to fully or partially replace some traditional services or products with renewables sources of energy in order to combat global climate change. The Climate Change theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Climate Change Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Eurobio Stock Analysis

When running Eurobio Scientific's price analysis, check to measure Eurobio Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurobio Scientific is operating at the current time. Most of Eurobio Scientific's value examination focuses on studying past and present price action to predict the probability of Eurobio Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurobio Scientific's price. Additionally, you may evaluate how the addition of Eurobio Scientific to your portfolios can decrease your overall portfolio volatility.